<VariationArchive RecordType="classified" VariationID="1076336" VariationName="NC_000021.8:g.(?_44478245)_(44485815_?)del" VariationType="Deletion" Accession="VCV001076336" Version="4" NumberOfSubmissions="2" NumberOfSubmitters="1" DateLastUpdated="2023-11-11" DateCreated="2021-05-10" MostRecentSubmission="2023-11-11">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1058103" VariationID="1076336">
      <GeneList>
        <Gene Symbol="CBS" FullName="cystathionine beta-synthase" GeneID="875" HGNC_ID="HGNC:1550" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>21q22.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="21" Accession="NC_000021.9" start="43053191" stop="43076873" display_start="43053191" display_stop="43076873" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="21" Accession="NC_000021.8" start="44473300" stop="44496471" display_start="44473300" display_stop="44496471" Strand="-" />
          </Location>
          <OMIM>613381</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000021.8:g.(?_44478245)_(44485815_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>21q22.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="21" Accession="NC_000021.8" innerStart="44478245" innerStop="44485815" display_start="44478245" display_stop="44485815" variantLength="7571" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000021.8" sequenceAccession="NC_000021" sequenceVersion="8" change="g.(?_44478245)_(44485815_?)del" Assembly="GRCh37">
            <Expression>NC_000021.8:g.(?_44478245)_(44485815_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000021.8:g.(?_44478245)_(44485815_?)del AND Classic homocystinuria" Accession="RCV001390205" Version="1">
        <ClassifiedConditionList TraitSetID="6456">
          <ClassifiedCondition DB="MedGen" ID="C0751202">Classic homocystinuria</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-06-07" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NC_000021.8:g.(?_44478245)_(44485815_?)del AND HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED" Accession="RCV003120599" Version="3">
        <ClassifiedConditionList TraitSetID="53">
          <ClassifiedCondition DB="MedGen" ID="C3150344">HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-04-16" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-04-16" NumberOfSubmissions="2" NumberOfSubmitters="1" DateCreated="2021-05-10" MostRecentSubmission="2023-11-11">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10338090</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12124992</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="6456" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1656" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">HOMOCYSTINURIA WITH OR WITHOUT RESPONSE TO PYRIDOXINE</ElementValue>
                <XRef Type="MIM" ID="236200" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Homocystinuria due to CBS deficiency</ElementValue>
                <XRef ID="Homocystinuria+due+to+CBS+deficiency/3462" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Homocystinuria due to cystathionine beta-synthase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cystathionine beta-synthase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">CBS deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Classic homocystinuria</ElementValue>
                <XRef ID="MONDO:0009352" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6667" />
                <XRef ID="6667" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Homocystinuria caused by cystathionine ÃŸ-synthase (CBS) deficiency is characterized by involvement of the eye (ectopia lentis and/or severe myopia), skeletal system (excessive height, long limbs, scolioisis, and pectus excavatum), vascular system (thromboembolism), and CNS (developmental delay/intellectual disability). All four ? or only one ? of the systems can be involved; expressivity is variable for all of the clinical signs. It is not unusual for a previously asymptomatic individual to present in adult years with only a thromboembolic event that is often cerebrovascular. Two phenotypic variants are recognized, B6-responsive homocystinuria and B6-non-responsive homocystinuria. B6-responsive homocystinuria is usually milder than the non-responsive variant. Thromboembolism is the major cause of early death and morbidity. IQ in individuals with untreated homocystinuria ranges widely, from 10 to 138. In B6-responsive individuals the mean IQ is 79 versus 57 for those who are B6-non-responsive. Other features that may occur include: seizures, psychiatric problems, extrapyramidal signs (e.g., dystonia), hypopigmentation of the skin and hair, malar flush, livedo reticularis, and pancreatitis.</Attribute>
                <XRef ID="NBK1524" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301697</ID>
                <ID Source="BookShelf">NBK1524</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS, 2010">
                <ID Source="PubMed">20298421</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2021">
                <URL>https://www.acmg.net/PDFLibrary/Methionine.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated Methionine +/- Elevated Homocysteine, Homocystinuria (Cystathionine beta-synthase deficiency), 2021</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2021">
                <URL>https://www.acmg.net/PDFLibrary/Methionine-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Elevated Methionine +/- Elevated Homocysteine, 2021</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/Homocystinuria-Transition.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Transition to Adult Health Care ACT Sheet, Homocystinuria (CBS Deficiency), 2012</CitationText>
              </Citation>
              <XRef ID="394" DB="Orphanet" />
              <XRef ID="C0751202" DB="MedGen" />
              <XRef ID="MONDO:0009352" DB="MONDO" />
              <XRef Type="MIM" ID="236200" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="53" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="8909" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED</ElementValue>
                <XRef ID="575096" DB="NCBI for submitter" />
                <XRef Type="Allelic variant" ID="613381.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613381.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613381.0013" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613381.0014" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613381.0004" DB="OMIM" />
                <XRef ID="236200" DB="OMIM" />
              </Name>
              <XRef ID="C3150344" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3117529" SubmissionDate="2021-01-07" DateLastUpdated="2021-05-10" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="NM_000071.2_21_Deletion (exons 6-15)|MedGen:C3150344" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001591846" DateUpdated="2021-05-10" DateCreated="2021-05-10" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-06-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10338090</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12124992</ID>
          </Citation>
          <Comment>This variant is an out-of-frame deletion of the genomic region encompassing exons 6-15 of the CBS gene. This is expected to create a premature translational stop signal and result in an absent or disrupted protein product. This variant has not been reported in the literature in individuals with CBS-related conditions. Loss-of-function variants in CBS are known to be pathogenic (PMID: 10338090, 12124992). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CBS" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000021.8:g.(?_44478245)_(44485815_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3150344" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7071070" SubmissionDate="2023-02-03" DateLastUpdated="2023-11-11" DateCreated="2023-02-13">
        <ClinVarSubmissionID localKey="NM_000071.2_Deletion (Exons 6-15)|MedGen:C3150344" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003790216" DateUpdated="2023-11-11" DateCreated="2023-02-13" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-04-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10338090</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12124992</ID>
          </Citation>
          <Comment>This variant is a gross deletion of the genomic region encompassing exon(s) 6-15 of the CBS gene. This deletion is out-of-frame, and is expected to create a premature termination codon and result in an absent or disrupted protein product. Loss-of-function variants in CBS are known to be pathogenic (PMID: 10338090, 12124992). This variant has not been reported in the literature in individuals affected with CBS-related conditions. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CBS" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000021.8:g.(?_44478245)_(44485815_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3150344" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12699154</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3117529" TraitType="Disease" MappingType="XRef" MappingValue="C3150344" MappingRef="MedGen">
        <MedGen CUI="C3150344" Name="HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7071070" TraitType="Disease" MappingType="XRef" MappingValue="C3150344" MappingRef="MedGen">
        <MedGen CUI="C3150344" Name="HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

